Acute and chronic effects of brimonidine 0.2% on intraocular pressure and pulsatile ocular blood flow in patients with primary open-angle glaucoma: An open-label, uncontrolled, prospective study

Clinical Therapeutics

Volumn 23, Issue 9, 2001, Pages 1519-1528

  Vetrugno, Michele ^a   Maino, Anna ^a   Cantatore, Francesco ^a   Ruggeri, Giuseppe ^a   Cardia, Luigi ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Brimonidine 0.2 ; Intraocular pressure; Primary open angle glaucoma; Pulsatile ocular blood flow

Indexed keywords

BRIMONIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; EYE BLOOD FLOW; FEMALE; HEMODYNAMICS; HUMAN; INTRAOCULAR PRESSURE; MALE; OPEN ANGLE GLAUCOMA; TONOMETRY; TREATMENT OUTCOME;

EID: 0034805445     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(01)80124-7     Document Type: Article

References (28)

1. Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: A review of safety, efficacy, dose response, and dosing studies
2. Effects of brimonidine on aqueous humor dynamics in human eyes
3. Functions mediated by α-adrenoceptors
4. Selective interaction of alpha-adrenoceptors with myogenic regulation of microvascular smooth muscle
5. 2-adrenoceptor constriction of rat skeletal muscle microvessels
6. Endothelium-dependent responses in large arteries and in the microcirculation
7. Binding and functional characterizations of alpha-2 adrenergic receptor subtypes on pig vascular endothelium
8. Effect of brimonidine on optic nerve blood flow in rabbits
9. Effect of brimonidine tartrate on ocular hemodynamic measurements
10. The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension
11. Prevent blindness America visual field screening study
12. The effect of topical clonidine on intraocular pressure
13. Follicular conjunctivitis associated with apraclonidine
14. Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents
15. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial
16. Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension
17. Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-Year results in glaucoma patients
18. Potential neuroprotective therapy for glaucomatous optic neuropathy
19. The probable involvement of factors other than intraocular pressure in the pathogenesis of glaucoma
20. Optic nerve head and blood supply in health and disease
21. Control of retinal and choroidal blood flow
22. The blood supply to the optic nerve head
23. Effect of different antiglaucomatous drugs on ocular perfusion pressures
24. The influence of timolol, clonidine and aminoclonidine on ocular blood flow in the rabbit and human subjects
25. Postural studies in pulsatile ocular blood flow: II. Chronic open angle glaucoma
26. Ocular blood flow changes with increased vascular resistance external and internal to the eye
27. Effect of acute intraocular pressure reduction on regional ocular blood flow
28. Autoregulation of ocular blood flow during changes in intraocular pressure: Preliminary results